Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Arif Bilal. Insider active across 1 company, notably Sarepta Therapeutics, Inc.. Aggregated, 20 disclosures have been recorded. Breakdown: 0 buy · 6 sells. Total volume traded: €1.8m. History available since 1 March 2023. The latest transaction was disclosed on 10 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Arif Bilal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
523 shares@ US$100.131.7% of flowCommon StockSEC:0000950170-25-037524:0
17,500 sharesCommon StockSEC:0000950170-25-036691:0
281 shares@ US$101.341.0% of flowCommon StockSEC:0000950170-25-035005:0
719 shares@ US$103.772.6% of flowCommon StockSEC:0000950170-25-032761:0
5,580 shares@ US$162.3130.0% of flowCommon StockSEC:0000950170-24-077518:2
2,352 shares@ US$164.6412.8% of flowCommon StockSEC:0000950170-24-077518:1
1,055 shares@ US$163.835.7% of flowCommon StockSEC:0000950170-24-077518:3
300 shares@ US$164.611.6% of flowCommon StockSEC:0000950170-24-077518:4
700 shares@ US$166.103.9% of flowCommon StockSEC:0000950170-24-077518:5
224 shares@ US$167.131.2% of flowCommon StockSEC:0000950170-24-077518:6
3,898 shares@ US$163.2321.2% of flowCommon StockSEC:0000950170-24-077518:7
6,250 sharesCommon StockSEC:0000950170-24-077518:0
506 shares@ US$120.492.0% of flowCommon StockSEC:0000950170-24-029533:0
285 shares@ US$125.321.2% of flowCommon StockSEC:0000950170-24-027494:0
251 shares@ US$126.191.0% of flowCommon StockSEC:0000950170-24-026606:0
3,682 shares@ US$80.349.7% of flowCommon StockSEC:0001209191-23-057558:0
307 shares@ US$136.661.4% of flowCommon StockSEC:0001209191-23-023064:0
314 shares@ US$153.191.6% of flowCommon StockSEC:0001209191-23-018018:0
186 shares@ US$157.211.0% of flowCommon StockSEC:0001209191-23-017403:0
80 shares@ US$147.570.4% of flowCommon StockSEC:0001209191-23-016058:0
About Arif Bilal
Arif Bilal is a declarant linked to Sarepta Therapeutics, Inc., where the listed role is Chief Tech Ops Officer. He has 20 filings in total, and across the 20 sampled filings between 2023-03-03 and 2025-03-11, the cumulative sell amount is EUR 1788236, with a modal transaction nature of tax withholding.